Stress proteins and glial functions: Possible therapeutic targets for neurodegenerative disorders

Pharmacology and Therapeutics

Volumn 97, Issue 1, 2003, Pages 35-53

  Kimura, M ^c   Kitamura, Yoshihisa ^a   Nomura, Yasuyuki ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NONE

Author keywords

Alzheimer's disease; Amyloid clearance; Brain ischemia; Microglia; Molecular chaperones; Neuroprotection

Indexed keywords

1 [6 (2 CARBOXYPYRROLIDIN 1 YL) 6 OXOHEXANOYL]PYRROLIDINE 2 CARBOXYLIC ACID; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLSALICYLIC ACID; ALZHEIMER DISEASE VACCINE; CELECOXIB; CHAPERONE; CYCLOPENTENONE DERIVATIVE; GELDANAMYCIN; HEAT SHOCK PROTEIN; HEME OXYGENASE 1; HYDROXYCHLOROQUINE; HYPOCHOLESTEROLEMIC AGENT; IBUPROFEN; INDOMETACIN; INTERLEUKIN 6; MESSENGER RNA; MEVINOLIN; NAPROXEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTEIN DISULFIDE ISOMERASE; RIFAMPICIN; RO 63 8695; SALICYLIC ACID; SIMVASTATIN; SULINDAC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; AMYLOID BETA PROTEIN; CYTOKINE;

ADOPTIVE IMMUNOTHERAPY; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL TYPE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GLIA CELL; HUMAN; HYPOXIA; IMMUNOREACTIVITY; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; REGULATORY MECHANISM; STEM CELL; VACCINATION; ANIMAL; DEGENERATIVE DISEASE; GLIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CYTOKINES; HEAT-SHOCK PROTEINS; HUMANS; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROGLIA; STEM CELL TRANSPLANTATION;

EID: 0037216148     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(02)00301-7     Document Type: Review

References (201)

1. Alves-Rodrigues A., Gregori L., Figueiredo-Pereira M.E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21:1998;516-520.
2. Amici C., Sistonen L., Santoro M.G., Morimoto R.I. Antiproliferative prostaglandins activate heat shock transcription factor. Proc Natl Acad Sci USA. 89:1992;6227-6231.
3. Anthony J.C., Breitner J.C., Zandi P.P., Meyer M.R., Jurasova I., Norton M.C., Stone S.V. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology. 54:2000;2066-2071.
4. Araya R., Uehara T., Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett. 439:1998;168-172.
5. Asea A., Kraeft S.-K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., Koo G.C., Calderwood S.K. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as chaperone and cytokine. Nat Med. 6:2000;435-442.
6. Auluck P.K., Chan H.Y.E., Trojanowski J.Q., Lee V.M.-Y., Bonini N.M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 295:2002;865-868.
7. Bard F., Cannon C., Barbour R., Burke R.-L., Games D., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Lieberburg I., Motter R., Nguyen M., Soriano F., Vasquez N., Weiss K., Weiss K., Welch B., Seubert P., Schenk D., Yednock T. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 6:2000;916-919.
8. 2+ accumulation. Proc Natl Acad Sci USA. 92:1995;9328-9332.
9. Beere H.M., Wolf B.B., Cain K., Mosser D.D., Mahboubi A., Kuwana T., Tailor P., Morimoto R.I., Cohen G.M., Green D.R. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol. 2:2000;469-475.
10. Bhat N.R., Sharma K.K. Microglial activation by small heat shock protein, α-crystallin. Neuroreport. 10:1999;2869-2873.
11. Björklund A., Lindvall O. Cell replacement therapies for ventral nervous system disorders. Nat Neurosci. 3:2000;537-544.
12. Björklund L.M., Sánchez-Pernaute R., Chung S., Andersson T., Chen I.Y.C., McNaugh K.St.P., Brownell A.-L., Jenkins B.G., Wahlestedt C., Kim K.-S., Isacson O. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA. 99:2002;2344-2349.
13. 2. Nature. 390:1997;622-625.
14. Brazelton T.R., Rossi F.M., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science. 290:2000;1775-1779.
15. Bruce A.J., Boling W., Kidny M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med. 2:1996;788-794.
16. Bruey J.-M., Ducasse C., Bonniaud P., Ravagnan L., Susin S.A., Diaz-Latoud C., Gurbuxani S., Arrigo A.-P., Kroemer G., Solary E., Garrido C. Hsp27 negatively regulates cell death by interacting with cytochrome c. Nat Cell Biol. 2:2000;645-652.
17. Brüstle O., Choudhary K., Karram K., Hüttner A., Murray K., Dubois-Dalcq M., McKay R.D.G. Chimeric brains generated by intraventricular transplantation of fetal human brain cells into embryonic rats. Nat Biotechnol. 16:1998;1040-1044.
18. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., Taddei N., Ramponi G., Dobson C.M., Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:2002;507-511.
19. Bukau B., Horwich A.L. The Hsp70 and Hsp60 chaperone machines. Cell. 92:1998;351-366.
20. Cahill C.M., Waterman W.R., Xie Y., Auron P.E., Calderwood S.K. Transcriptional repression of the prointerleukin 1β gene by heat shock factor 1. J Biol Chem. 271:1996;24874-24879.
21. Calhoun M.E., Burgermeister P., Phinney A.L., Stalder M., Tolnay M., Wiederhold K.-H., Abramowski D., Sturchler-Pierrat C., Sommer B., Staufenbiel M., Jucker M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA. 96:1999;14088-14093.
22. Check E. Nerve inflammation halts trial for Alzheimer's drug. Nature. 415:2002;462.
23. Chen K., Gunter K., Maines M.D. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J Neurochem. 75:2000;304-313.
24. Christie R.H., Freeman M., Hyman B.T. Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am J Pathol. 148:1996;399-403.
25. 2 after transient global forebrain ischemia in rat. Stroke. 27:1996;527-535.
26. Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonist. J Neurosci. 20:2000;558-567.
27. Conway K.A., Rochet J.-C., Bieganski R.M., Lansbury P.T. Jr. Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science. 294:2001;1346-1349.
28. Coughlan C.M., Breen K.C. Factors influencing the processing and function of the amyloid β precursor protein: a potential therapeutic target in Alzheimer's disease? Pharmacol Ther. 86:2000;111-144.
29. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.-C., Paul S.M., Holtzman D.M. Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 98:2001;8850-8855.
30. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in mouse model of Alzheimer's disease. Science. 295:2002;2264-2267.
31. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.-H., Bronsnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
32. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature. 383:1996;710-713.
33. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature. 382:1996;716-719.
34. Evert B.O., Wüllner U., Klockgether T. Cell death in polyglutamine disease. Cell Tissue Res. 301:2000;189-204.
35. 2 in neurodegeneration. Neurochem Int. 30:1997;517-522.
36. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kühl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo. Proc Natl Acad Sci USA. 98:2001;5856-5861.
37. Feinstein D.L., Galea E., Aquino D.A., Li G.C., Xu H., Reis D.J. Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFκB activation. J Biol Chem. 271:1996;17724-17732.
38. Findeis M.A. Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization. Biochim Biophys Acta. 1502:2000;76-84.
39. 2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812.
40. Freed C.R. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci USA. 99:2002;1755-1757.
41. Freed C.R., Greene P.E., Breeze R.E., Tsai W.-Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med. 344:2001;710-719.
42. Funato H., Yoshimura M., Yamazaki T., Saido T.C., Ito Y., Yokofujita J., Okeda R., Ihara Y. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain. Am J Pathol. 152:1998;983-992.
43. Gage F.H. Mammalian neural stem cells. Science. 287:2000;1433-1438.
44. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 5:1999;698-701.
45. Glover J.R., Lindquist S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell. 94:1998;73-82.
46. Goloubinoff P., Mogk A., Zvi A.P.B., Tomoyasu T., Bukau B. Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network. Proc Natl Acad Sci USA. 96:1999;13732-13737.
47. Götz J., Chen F., van Dorpe J., Nitsch R.M. Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils. Science. 293:2001;1491-1495.
48. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science. 274:1996;1383-1385.
49. Hamazaki H. Cathepsin D is involved in the clearance of Alzheimer's β-amyloid protein. FEBS Lett. 396:1996;139-142.
50. Hamos J.E., Oblas B., Pulaski-Salo D., Welch W.J., Bole D.G., Drachman D.A. Expression of heat shock proteins in Alzheimer's disease. Neurology. 41:1991;345-350.
51. Hartl F.U. Molecular chaperones in cellular protein folding. Nature. 381:1996;571-580.
52. He T.-C., Chan T.A., Vogelstein B., Kinzler K.W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:1999;335-345.
53. 2: a growth-dependent response mediated by activation of heat shock transcription factor. Mol Cell Biol. 12:1992;1528-1534.
54. Holcomb L., Gordon M.N., McGowan E., Yu X., Benkovic S., Jantzen P., Wright K., Saad I., Mueller R., Morgan D., Sanders S., Zehr C., O'Campo K., Hardy J., Prada C.-M., Eckman C., Younkin S., Hsiao K., Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 4:1998;97-100.
55. Hori R., Kashiba M., Toma T., Yachie A., Goda N., Makino N., Soejima A., Nagasawa T., Nakabayashi K., Suematsu M. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. J Biol Chem. 277:2002;10712-10718.
56. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Ab elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
57. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., Witztum J.L., Funk C.D., Conrad D., Glass C.K. Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature. 400:1999;378-382.
58. Huang Q., Alvares K., Chu R., Bradfield C.A., Reddy J.K. Association of peroxisome proliferator-activated receptor and Hsp72. J Biol Chem. 269:1994;8493-8497.
59. Imai F., Sawada M., Suzuki H., Kiya N., Hayakawa M., Nagatsu T., Marunouchi T., Kanno T. Migration activity of microglia and macrophages into rat brain. Neurosci Lett. 237:1997;49-52.
60. Imai F., Sawada M., Suzuki H., Zlokovic B.V., Kojima J., Kuno S., Nagatsu T., Nitatori T., Uchiyama Y., Kanno T. Exogenous microglia enter the brain and migrate into ischaemic hippocampal lesions. Neurosci Lett. 272:1999;127-130.
61. in 't Veld B.A., Ruitenberg A., Hofman A., Launer L.J., van Duijn C.M., Stijnen T., Breteler M.M.B., Stricker B.H.C. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 345:2001;1515-1521.
62. Ishikawa A., Kubota Y., Murayama T., Nomura Y. Cell death by 1-chloro-2,4-dinitrobenzene, an inhibitor of thioredoxin reductase and its dual regulation by nitric oxide in rats. Neurosci Lett. 277:1999;99-102.
63. 1-42-degrading catabolic pathway in the brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med. 6:2000;143-150.
64. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., Gerard C., Hama E., Lee H.-J., Saido T.C. Metabolic regulation of brain Aβ by neprilysin. Science. 292:2001;1550-1552.
65. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T.J., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
66. Jiang C., Ting A.T., Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
67. Jiang Y., Woronicz J.D., Liu W., Goeddel D.V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 283:1999;543-546.
68. Jick H., Zornberg G.L., Jick S.S., Drachman D.A. Statins and the risk of dementia. Lancet. 356:2000;1627-1631.
69. Kakimura J.-I., Kitamura Y., Taniguchi T., Shimohama S., Gebicke-Haerter P.J. BiP/GRP78-induced production of cytokines and uptake of amyloid-β(1-42) peptide in microglia. Biochem Biophys Res Commun. 281:2001;6-10.
70. Kakimura J.-I., Kitamura Y., Takata K., Umeki M., Suzuki S., Shibagaki K., Taniguchi T., Nomura Y., Gebicke-Haerter P.J., Smith M.A., Perry G., Shimohama S. Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins. FASEB J (February 28, 2002) 10.1096/fj.01-0530fje. Summary FASEB J. 16:2002;601-603. Summary.
71. Kakio A., Nishimoto S., Yanagisawa K., Kozutsumi Y., Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem. 276:2001;24985-24990.
72. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., Morihara T., Yoneda T., Gomi F., Mori Y., Nakano Y., Takeda J., Tsuda T., Itoyama Y., Murayama O., Takashima A., St. George-Hyslop P., Takeda M., Tohyama M. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nat Cell Biol. 1:1999;479-485.
73. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13:1999;1211-1233.
74. Kawasaki H., Mizuseki K., Nishikawa S., Kaneko S., Kuwana Y., Nakanishi S., Nishikawa S.I., Sasai Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron. 28:2000;31-40.
75. Kawashima A., Oda Y., Yachie A., Koizumi S., Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 33:2002;125-130.
76. Kettenmann H., Ransom B.R. Neuroglia. 1995;Oxford University Press, New York and Oxford.
77. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikishiba K., Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528:1990;21-24.
78. Kitamura Y., Shimohama S., Kamoshima Y., Matsuoka Y., Nomura Y., Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun. 232:1997;418-421.
79. Kitamura Y., Furukawa M., Matsuoka Y., Tooyama I., Kimura H., Nomura Y., Taniguchi T. In vitro and in vivo induction of heme oxygenase-1 in rat glial cells: possible involvement of nitric oxide production from inducible nitric oxide synthase. Glia. 22:1998;138-148.
80. Kitamura Y., Matsuoka Y., Nomura Y., Taniguchi T. Induction of inducible nitric oxide synthase and heme oxygenase-1 in rat glial cells. Life Sci. 62:1998;1717-1721.
81. Kitamura Y., Kakimura J., Matsuoka Y., Nomura Y., Gebicke-Haerter P.J., Taniguchi T. Activators of peroxisome proliferator-activated receptor-γ (PPAR-γ) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. Neurosci Lett. 262:1999;129-132.
82. Kitamura Y., Ota T., Matsuoka Y., Tooyama I., Kimura H., Shimohama S., Nomura Y., Gebicke-Haerter P.J., Taniguchi T. Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells. Glia. 25:1999;154-164.
83. Kitamura Y., Shimohama S., Koike H., Kakimura J., Matsuoka Y., Gebicke-Haerter P.J., Taniguchi T. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem Biophys Res Commun. 254:1999;582-586.
84. Kitamura Y., Taniguchi T., Shimohama S. Apoptotic cell death in neurons and glial cells: implications for Alzheimer's disease. Jpn J Pharmacol. 79:1999;1-5.
85. Kitamura Y., Takata K., Kakimura J., Umeki M., Azukawa S., Suzuki S., Taniguchi T. Aryl hydrocarbon receptor nuclear translocator is induced by kainic acid in rat hippocampal glial cells. Neurosci Lett. 291:2000;117-120.
86. Kitamura Y., Taniguchi T., Kimura H., Nomura Y., Gebicke-Haerter P.J. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J Neuroimmunol. 106:2000;95-104.
87. Kitamura Y., Ishida Y., Takata K., Kakimura J., Mizutani H., Shimohama S., Akaike A., Taniguchi T. α-Synuclein protein is not scavenged in neuronal loss induced by kainic acid and focal ischemia. Brain Res. 898:2001;181-185.
88. 2 and interleukin-4 in Toll-like receptor-4-mutant glial cells. Eur J Pharmacol. 411:2001;223-230.
89. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:1995;813-819.
90. 2 and its inhibition by intracellular glutathione. Biochem Pharmacol. 45:1993;2457-2464.
91. 2-induced expression of the rat heme oxygenase gene. J Biol Chem. 270:1995;21779-21784.
92. Kojro E., Gimpl G., Lammich S., März W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM10. Proc Natl Acad Sci USA. 98:2001;5815-5820.
93. Kol A., Lichman A.H., Finberg R.W., Libby P., Kurt-Jones E.A. Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 164:2000;13-17.
94. Kouchi Z., Sorimachi H., Suzuki K., Ishiura S. Proteasome inhibitors induce the association of Alzheimer's amyloid precursor protein with Hsc73. Biochem Biophys Res Commun. 254:1999;804-810.
95. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-316.
96. 1-42 amyloidogenesis. FEBS Lett. 416:1997;117-121.
97. Kurochkin I.V., Goto S. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:1994;33-37.
98. Lange A.E., Lozano A.M. Parkinson's disease: second of two parts. N Engl J Med. 339:1998;1130-1143.
99. Lee J.-H., Takahashi T., Yasuhara N., Inazawa J., Kamada S., Tsujimoto Y. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene. 18:1999;6183-6190.
100. Lee S.-H., Lumelsky N., Studer L., Auerbach J.M., McKay R.D. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol. 18:2000;675-679.
101. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 272:1997;3406-3410.
102. 2 by amyloid β-peptides in vitro. Biochemistry. 35:1996;9407-9414.
103. Lewis J., Devin A., Miller A., Lin Y., Rodriguez Y., Neckers L., Liu Z.-G. Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation. J Biol Chem. 275:2000;10519-10526.
104. Lewis J., Dickson D.W., Lin W.-L., Chisholm L., Corral A., Jones G., Yen S.-H., Sahara N., Skipper L., Yager D., Eckman C., Hardy J., Hutton M., McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293:2001;1487-1491.
105. Lim P.G., Yang F., Chu T., Chen P., Beech W., Teter B., Tran T., Ubeda O., Hsiao Ashe K., Frautschy S.A., Cole G.M. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci. 20:2000;5709-5714.
106. Maeda Y., Matsumoto M., Hori O., Kuwabara K., Ogawa S., Yan S.D., Ohtsuki T., Kinoshita T., Kamada T., Stern D.M. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: a paracrine mechanism potentially enhancing neuron survival. J Exp Med. 180:1994;2297-2308.
107. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 37:1997;517-554.
108. Massa S.M., Swanson R.A., Sharp F.R. The stress gene response in brain. Cerebrovasc Brain Metab Rev. 8:1996;95-158.
109. Matsuoka Y., Kitamura Y., Okazaki M., Kakimura J., Tooyama I., Kimura H., Taniguchi T. Kainic acid induction of heme oxygenase in vivo and in vitro. Neuroscience. 85:1998;1223-1233.
110. Matsuoka Y., Okazaki M., Kitamura Y., Takata K., Tooyama I., Kimura H., Taniguchi T. Kainic acid-induced inducible cyclooxygenase and c-Jun phosphorylation in the rat hippocampal formation. Brain Res. 836:1999;213-217.
111. Matsuoka Y., Okazaki M., Zhao H., Asai S., Ishikawa K., Kitamura Y. Phosphorylation of c-Jun and its localization with heme oxygenase-1 and cyclooxygenase-2 in CA1 pyramidal neurons after transient forebrain ischemia. J Cereb Blood Flow Metab. 19:1999;1247-1255.
112. Matsuoka Y., Picciano M., Malester B., LaFrancos J., Zehr C., Daeschner J.M., Olschowka J.A., Fonseca M.I., O'Banion M.K., Tenner A.J., Lemere C.A., Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol. 158:2001;1345-1354.
113. Mattson M.P., LaFerla F.M., Chan S.L., Leissring M.A., Shepel P.N., Geiger J.D. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23:2000;222-229.
114. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev. 21:1995;195-218.
115. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:1996;425-432.
116. Mezey É., Chandross K.J., Harta G., Maki R.A., McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 290:2000;1779-1782.
117. Minota S., Cameron B., Welch W.J., Winfield J.B. Autoantibodies to the constitutive 73-kD member of the hsp70 family of heat shock proteins in systemic lupus erythematosus. J Exp Med. 168:1988;1475-1480.
118. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., Duff K., Jantzen P., DiCarlo G., Wilcock D., Connor K., Hatcher J., Hope C., Gordon M., Arendash G.W. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
119. Morshead C.M., Benveniste P., Iscove N.N., van der Kooy D. Mematopoietic competence is a rare property of neural stem cells that may depend on genetic and epigenetic alterations. Nat Med. 8:2002;268-273.
120. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S.T., Hampel H., Hull M., Landreth G., Lue L.-F., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyama I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging. 21:2000;383-421.
121. Nogawa S., Zhang F., Ross E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci. 17:1997;2746-2755.
122. Nomura Y., Yamanaka Y., Kitamura Y., Arima T., Ohnuki T., Oomura Y., Sasaki K., Nagashima K., Ihara Y. Senescence-accelerated mouse: neurochemical studies of aging. Ann N Y Acad Sci. 786:1996;410-418.
123. Ono K., Takii T., Onozaki K., Ikawa M., Okabe M., Sawada M. Migration of exogenous immature hematopoietic cells into adult mouse brain parenchyma under GFP-expressing bone marrow chimera. Biochem Biophys Res Commun. 262:1999;610-614.
124. Ooboshi H., Ibayashi S., Takada J., Yao H., Kitazono T., Fujishima M. Adenovirus-mediated gene transfer to ischemic brain: ischemic flow threshold for transgene expression. Stroke. 32:2001;1043-1047.
125. Panahian N., Yoshiura M., Maines M.D. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem. 72:1999;1187-1203.
126. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., Weichselbaum R., Nalin C., Alnemri E.S., Kufe D., Kharbanda S. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19:2000;4310-4322.
127. Paresce D.M., Gohsh R.N., Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron. 17:1996;553-565.
128. Pasinetti G.M., Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 87:1998;319-324.
129. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., Hidalgo J. Strongly compromised inflammatory response to brain injury in interleukin-6 deficient mice. Glia. 25:1999;343-357.
130. Pepys M.B., Herbert J., Hutchinson W.L., Tennent G.A., Lachmann H.J., Gallimore J.R., Lovat L.B., Bartfai T., Alanine A., Hertel C., Hoffmann T., Jakob-Roetne R., Norcross R.D., Kemp J.A., Yamamura K., Suzuki M., Taylor G.W., Murray S., Thompson D., Purvis A., Kolstoe S., Wood S.P., Hawkins P.N. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 417:2002;254-259.
131. 2. Proc Natl Acad Sci USA. 96:1999;4668-4673.
132. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron retilization. Proc Natl Acad Sci USA. 94:1997;10919-10924.
133. Poss K.D., Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 94:1997;10925-10930.
134. Poss K.D., Thomas M.J., Ebralidze A.K., O'Dell T.J., Tonegawa S. Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron. 15:1995;867-873.
135. Qiu W.Q., Walsh Q.D., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Savavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid β-protein by degradation. J Biol Chem. 273:1998;32730-32738.
136. Qu T., Brannen C.L., Kim H.M., Sugaya K. Human neural stem cells improve cognitive function of aged brain. Neuroreport. 12:2001;1127-1132.
137. Rajdev S., Hara K., Kokubo Y., Mestril R., Dillmann W., Weinstein P.R., Sharp F.R. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann Neurol. 47:2000;782-791.
138. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryant T., Tint G.S., Wang R., Mercken M., Petanceska S.S., Duff K.E. A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 8:2001;890-899.
139. Renkawek K., Stege G.J., Bosman G.J. Dementia, gliosis and expression of the small heat-shock proteins hsp27 and αB-crystallin in Parkinson's disease. Neuroreport. 10:1999;2273-2276.
140. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
141. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
142. Rossi A., Kapahi P., Natoli G., Takahashi T., Karrin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 403:2000;103-108.
143. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature. 396:1998;336-342.
144. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2:2000;476-483.
145. Samali A., Cai J., Zhivotovsky B., Jones D.P., Orrenius S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of Jurkat cells. EMBO J. 18:1999;2040-2048.
146. Sato N., Imaizumi K., Manabe T., Taniguchi M., Hitomi J., Katayama T., Yoneda T., Morihara T., Yasuda Y., Takagi T., Kudo T., Tsuda T., Itoyama Y., Makifuchi T., Fraser P.E., St. Goerge-Hyslop P., Tohyama M. Increased production of β-amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2. J Biol Chem. 276:2001;2108-2114.
147. Sato S., Fujita N., Tsuruo T. Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA. 97:2000;10832-10837.
148. Sawada M., Suzumura A., Marunouchi T. Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells. Int J Dev Neurosci. 13:1995;253-264.
149. Sawada M., Imai F., Suzuki H., Hayakawa M., Kanno T., Nagatsu T. Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain. FEBS Lett. 433:1998;37-40.
150. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., Hu K., Huang J., Johnson-Wood K., Khan K., Kholodenko D., Lee M., Liao Z., Lieberburg I., Motter R., Mutter L., Soriano F., Shopp G., Vasquez N., Vandevert C., Walker S., Wogulis M., Yednock T., Games D., Seubert P. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
151. Schipper H.M., Cissé S., Stopa E.G. Expression of hemeoxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol. 37:1995;758-769.
152. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399(suppl.):1999;A23-A31.
153. Sharp F.R., Massa S.M., Swanson R.A. Heat-shock protein protection.
154. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 106:2000;1489-1499.
155. Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., Perry G. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol. 145:1994;42-47.
156. Song H., Stevens C.F., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature. 417:2002;39-44.
157. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., Frangione B. β-Sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med. 4:1998;822-826.
158. Sparks D.L. Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann N Y Acad Sci. 826:1997;128-146.
159. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., Pavletich N.P. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell. 89:1997;239-250.
160. Stege G.J.J., Renkawek K., Overkamp P.S.G., Verschuure P., van Rijk A.F., Reijnen-Aalbers A., Boelens W.C., Bosman G.J.C.G.M., de Jong W.W. The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity. Biochem Biophys Res Commun. 262:1999;152-156.
161. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis. 3:1996;51-63.
162. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA. 97:2000;4844-4849.
163. Suzuki H., Imai F., Kanno T., Sawada M. Preservation of neurotrophin expression in microglia that migrate into the gerbil's brain across the blood-brain barrier. FEBS Lett. 312:2001;95-98.
164. Svendsen C.N., Caldwell M.A., Shen J., ter Borg M.G., Rosser A.E., Tyers P., Karmiol S., Dunnett S.B. Long-term survival of human central nervous system progenitor cells transplanted into a rat model of Parkinson's disease. Exp Neurol. 148:1997;135-146.
165. Swanson H.I., Chan W.K., Bradfield C.A. DNA binding specificities and pairing rules of the An receptor, ARNT, and SIM proteins. J Biol Chem. 270:1995;26292-26302.
166. Takayama S., Sato T., Krajewski S., Kochelm K., Iriem S., Millan J.A., Reed J.C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell. 80:1995;279-284.
167. Takayama S., Xie Z., Reed J.C. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem. 274:1999;781-786.
168. Takeda T., Hosokawa M., Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of accelerated senescence. J Am Geriart Soc. 39:1991;911-919.
169. Takemura M., Nakamura S., Akiguchi I., Ueno M., Oka N., Ishikawa S., Shimada A., Kimura J., Takeda T. β/A4 protein like immunoreactive granular structures in the brain of senescence-accelerated mouse. Am J Pathol. 142:1993;1887-1897.
170. Takeuchi A., Irizarry M.C., Duff K., Saido T.C., Ashe K.H., Hasegawa M., Mann D.M., Hyman B.T., Iwatsubo T. Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol. 157:2000;331-339.
171. Tamatani M., Che Y.H., Matsuzaki H., Ogawa S., Okado H., Miyake S., Mizuno T., Tohyama M. Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampal neurons. J Biol Chem. 274:1999;8531-8538.
172. Tamatani M., Matsuyama T., Yamaguchi A., Mitsuda N., Tsukamoto Y., Taniguchi M., Che Y.H., Ozawa K., Hori O., Nishimura H., Yamashita A., Okabe M., Yanagi H., Stern D.M., Ogawa S., Tohyama M. ORP150 protects against hypoxia/ischemia-induced neuronal death. Nat Med. 7:2001;317-323.
173. Tanaka S., Uehara T., Nomura Y. Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem. 275:2000;10388-10393.
174. Tanaka S., Kitagawa K., Ohtsuki T., Yagita Y., Takasawa K., Hori M., Matsumoto M. Synergistic induction of HSP40 and HSC70 in the mouse hippocampal neurons after cerebral ischemia and ischemic tolerance in gerbil hippocampus. J Neurosci Res. 67:2002;37-47.
175. Tha K.K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R., Hayashi Y., Nomura Y. Changes in expressions of proinflammatory cytokines IL-1β, TNF-α and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885:2000;25-31.
176. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science. 282:1998;1145-1147.
177. Thress K., Song J., Morimoto R.I., Kornbluth S. Reversible inhibition of Hsp70 chaperone function by Scythe and Reaper. EMBO J. 20:2001;1033-1041.
178. Uehara T., Kaneko M., Tanaka S., Okuma Y., Nomura Y. Possible involvement of p38 MAP kinase in HSP70 expression induced by hypoxia in rat primary astrocytes. Brain Res. 823:1999;226-230.
179. Uehara T., Kikuchi Y., Nomura Y. Caspase activation accompanying cytochrome c release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J Neurochem. 72:1999;196-205.
180. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:1998;97-120.
181. Van Gool W.A., Weinstein H.C., Scheltens P.K., Walstra G.J.M. Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet. 358:2001;455-460.
182. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
183. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L., Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 23:1999;425-428.
184. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenese activity. Nature. 414:2001;212-216.
185. Wegiel J., Wisniewski H.M. The complex of microglial cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol. 81:1990;116-124.
186. Wicker S., Maurizi M.R., Gottesman S. Posttranslational quality control: folding, refolding, and degrading proteins. Science. 286:1999;1888-1893.
187. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: a novel target for the modulation of inflammatory response. Nat Med. 2:1996;87-90.
188. Wolozin B. A fluid connection: cholesterol and Aβ Proc Natl Acad Sci USA. 98:2001;5371-5373.
189. Wyss-Coray T., Lin C., Yan F., Yu G.-Q., Rohde M., McConlogue L., Masliah E., Mucke L. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med. 7:2001;612-618.
190. Xanthoudakis S., Nicholson D.W. Heat-shock proteins as death determinants. Nat Cell Biol. 2:2000;E163-E164.
191. Xanthoudakis S., Roy S., Rasper D., Hennessey T., Aubin Y., Cassady R., Tawa P., Ruel R., Rosen A., Nicholson D.W. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 18:1999;2049-2056.
192. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 103:1999;129-135.
193. Yamada K., Nabeshima T. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther. 88:2000;93-113.
194. Yamaguchi H., Sugihara S., Ogawa A., Saido T.C., Ihara Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. 95:1998;217-222.
195. Yang Y., Turner R.S., Gaut J.R. The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40 and Aβ42 secretion. J Biol Chem. 273:1998;25552-25555.
196. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.
197. Yasojima K., McGeer E.G., McGeer P.L. Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919:2001;115-121.
198. Yenari M.A., Fink S.L., Sun G.H., Chang L.K., Patel M.K., Kunis D.M., Onley D., Ho D.Y., Sapolsky R.M., Steinberg G.K. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol. 44:1998;584-591.
199. Yin M.-J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature. 396:1998;77-80.
200. Zhang S.C., Wernig M., Duncan I.D., Brüstle O., Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol. 19:2001;1129-1133.
201. Zolkiewski M. ClpB cooperates with DnaK, DnaJ, and GrpE in suppressing protein aggregation. J Biol Chem. 274:1999;28083-28086.